1996
DOI: 10.1097/00001756-199603220-00011
|View full text |Cite
|
Sign up to set email alerts
|

NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

12
221
1
7

Year Published

2002
2002
2020
2020

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 250 publications
(241 citation statements)
references
References 0 publications
12
221
1
7
Order By: Relevance
“…8). Sprouting has been reported previously after infusion of BNDF and NT-3 in deafened guinea pigs (Miller et al, 2007;Staecker et al, 1996;Wise et al, 2005), although in the Wise et al study (with no ICES) the sprouted fibers grew upward into the spiral limbus of the degenerated organ of Corti. Thus, the applied electrical stimulation in our study may have guided or attracted fibers to grow into the region above the electrode within the scala tympani.…”
Section: Intracochlear Infusion Of Neurotrophinsmentioning
confidence: 53%
See 2 more Smart Citations
“…8). Sprouting has been reported previously after infusion of BNDF and NT-3 in deafened guinea pigs (Miller et al, 2007;Staecker et al, 1996;Wise et al, 2005), although in the Wise et al study (with no ICES) the sprouted fibers grew upward into the spiral limbus of the degenerated organ of Corti. Thus, the applied electrical stimulation in our study may have guided or attracted fibers to grow into the region above the electrode within the scala tympani.…”
Section: Intracochlear Infusion Of Neurotrophinsmentioning
confidence: 53%
“…As mentioned previously, several recent in vivo studies have reported that direct cochlear infusion of neurotrophins (NTs), particularly BDNF, can promote improved SG survival following deafness (Gillespie et al, 2003;Miller et al, 1997;Miller et al, 2007;Shinohara et al, 2002;Staecker et al, 1996). Further, ICES has been reported to be additive to the effects of NTs (Kanzaki et al, 2002;Shepherd et al,2005;Pettingill et al, 2007) in reducing SG degeneration.…”
Section: Intracochlear Infusion Of Neurotrophinsmentioning
confidence: 91%
See 1 more Smart Citation
“…Recent treatment strategies of bionic cochlear implant use these growth factors to aid survival of cochlear ganglion neurons in deafened ear and enhancing therapeutic outcomes [10]. Many experimental studies have shown that whenever there is loss of neurotrophic support from these factors, the ganglion neurons appear unhealthy with smaller soma [19] and pyknotic, misshapen nuclei [23][24][25]. Other experimental studies on deafened animals have shown that on treatment with exogenous neurotrohic factors, the surviving spiral ganglion neurons appeared larger, and healthier with well defined nucleus, nucleolus and abundant Nissl substance [19,26].…”
Section: Resultsmentioning
confidence: 99%
“…Previous studies have shown that chronic delivery of neurotrophic factors such as brain derived neurotrophic factor (BDNF), neurotrophin-3 or GDNF can prevent the degeneration of spiral ganglion neurons (Staecker et al, 1996;Miller et al, 1997;Shinohara et al, 2002;Gillespie et al, 2003) and that chronic electrical stimulation promotes survival of these cells in the deafened cochlea (Lousteau, 1987;Leake et al, 1991;Leake et al, 1999;Leake and Rebscher, 2004). Furthermore, Shepherd et al (2005) suggested that application of electrical stimulation and neurotrophic factors concurrently may have an additive effect.…”
Section: Integrated Drug Deliverymentioning
confidence: 99%